Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial.
Derebail VK, Zhu J, Crawford ML, Garnier JR, Martin KA, Skinner S, Patel T, Froment A, Sketch MR, Szeto AH, Patel SM, Torrice CD, Tiefenbacher S, Adcock DM, Grant RP, Key NS, Crona DJ.
Derebail VK, et al. Among authors: grant rp.
Am J Kidney Dis. 2023 Mar;81(3):373-376. doi: 10.1053/j.ajkd.2022.09.011. Epub 2022 Nov 1.
Am J Kidney Dis. 2023.
PMID: 36328100
Clinical Trial.
No abstract available.